Real-time insider trades Start Free
Profitelligence
Eli Lilly and Company
LLY

Eli Lilly and Company

Dozier Eric Files Eli Lilly and Company (LLY) Form 4 - February 19, 2026

| Form 4 |Healthcare

Transactions

Insider Date Type Shares Price Value Own
Dozier Eric 2026-02-19 Sell 481 $0.00 $0.00 Direct
Profitelligence Profitelligence Alerts

Track LLY insider activity

Get alerts when Eli Lilly and Company executives trade their shares.

Set Up Alerts →

Advertisement

About Eli Lilly and Company

Eli Lilly and Company is a renowned pharmaceutical corporation that engages in the discovery, development, manufacturing, and marketing of pharmaceutical products worldwide. The company's core purpose is to create high-quality medications that address significant medical needs in areas such as oncology, immunology, neuroscience, and endocrinology. Eli Lilly is particularly noted for its pioneering work in diabetes care with products like insulin and for its innovative approach to treating complex health conditions. With a history dating back to 1876, the Indianapolis-based company blends scientific innovation with a commitment to improve patient outcomes. Eli Lilly’s role in the financial markets is significant due to its contributions to healthcare advancements and its influence on global pharmaceutical trends. The company's robust pipeline and emphasis on research and development underscore its potential to impact healthcare solutions and deliver sustainable growth. Its products and services are marketed globally, underlying its importance in the biopharmaceutical industry.

Exchange: NYSE Industry: Drug Manufacturers - General Company Website

Official SEC Documents

LLY
LLY Research
Insider trades, 8Ks, financials, technicals
Form 4 Insider Tracker
See what executives are buying and selling

Advertisement